Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes

Nature Medicine

Volumn 15, Issue 1, 2009, Pages 104-109

  Urano, Yasuteru ^a,b   Asanuma, Daisuke ^a   Hama, Yukihiro ^c,e   Koyama, Yoshinori ^c,f   Barrett, Tristan ^c,g   Kamiya, Mako ^a   Nagano, Tetsuo ^a   Watanabe, Toshiaki ^d   Hasegawa, Akira ^d   Choyke, Peter L ^c   Kobayashi, Hisataka ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Advanced Core Technology Department   (Japan)

^e NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^f GUNMA UNIVERSITY HOSPITAL   (Japan)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTON PUMP; TRASTUZUMAB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; INTERNALIZATION; LUNG CANCER; LUNG METASTASIS; LYSOSOME; MOLECULAR IMAGING; MOUSE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL;

ANIMALS; BALB 3T3 CELLS; CELL SURVIVAL; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENT DYES; HYDROGEN-ION CONCENTRATION; LUNG NEOPLASMS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; NIH 3T3 CELLS; RECEPTOR, ERBB-2; SUBSTRATE SPECIFICITY;

MUS;

EID: 58149357048     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1854     Document Type: Article

References (32)

1. Yamamoto, N. et al. Cellular dynamics visualized in live cells in vitro and in vivo by differential dual-color nuclear-cytoplasmic fluorescent-protein expression. Cancer Res. 64, 4251-4256 (2004).
2. Yamauchi, K. et al. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 68, 516-520 (2008).
3. Yang, M., Jiang, P. & Hoffman, R.M. Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time. Cancer Res. 67, 5195-5200 (2007).
4. Wu, A.M. & Senter, P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 23, 1137-1146 (2005).
5. Yarden, Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37, Suppl 4, S3-S8 (2001).
6. Miura, T. et al. Rational design principle for modulating fluorescence properties of fluorescein-based probes by photoinduced electron transfer. J. Am. Chem. Soc. 125, 8666-8671 (2003).
7. Ueno, T. et al. Rational principles for modulating fluorescence properties of fluorescein. J. Am. Chem. Soc. 126, 14079-14085 (2004).
8. Tanaka, K. et al. Rational design of fluorescein-based fluorescence probes. Mechanism-based design of a maximum fluorescence probe for singlet oxygen. J. Am. Chem. Soc. 123, 2530-2536 (2001).
9. Urano, Y. et al. Evolution of fluorescein as a platform for finely tunable fluorescence probes. J. Am. Chem. Soc. 127, 4888-4894 (2005).
10. Gabe, Y., Urano, Y., Kikuchi, K., Kojima, H. & Nagano, T. Highly sensitive fluorescence probes for nitric oxide based on boron dipyrromethene chromophore - rational design of potentially useful bioimaging fluorescence probe. J. Am. Chem. Soc. 126, 3357-3367 (2004).
11. Queen, C. et al. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA 86, 10029-10033 (1989).
12. Minta, A., Kao, J.P.Y. & Tsien, R.Y. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 264, 8171-8178 (1989).
13. Weissleder, R., Tung, C.H., Mahmood, U. & Bogdanov, A. Jr. In vivo imaging of tumors with proteaseactivated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378 (1999).
14. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284 (2000).
15. + exchange in gastric glands as measured with a cytoplasmic-trapped, fluorescent ph indicator. Proc. Natl. Acad. Sci. USA 81, 7436-7440 (1984).
16. de Silva, A.P. et al. Signaling recognition events with fluorescent sensors and switches. Chem. Rev. 97, 1515-1566 (1997).
17. Kollmannsberger, M., Rurack, K., Resch-Genger, U. & Daub, J. Ultrafast charge transfer in amino-substituted boron dipyrromethene dyes and its inhibition by cation complexation: a new design concept for highly sensitive fluorescent probes. J. Phys. Chem. A 102, 10211-10220 (1998).
18. Adie, E.J. et al. A pH-sensitive fluor, CypHer™ 5, used to monitor agonist-induced G protein-coupled receptor internalization in live cells. Biotechniques 33, 1152-1154 (2002).
19. Nwokolo, C.U., Payne-James, J.J., Silk, D.B., Misiewicz, J.J. & Loft, D.E. Palliation of malignant dysphagia by ethanol induced tumour necrosis. Gut 35, 299-303 (1994).
20. Hama, Y. et al. A target-cell specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res. 67, 2791-2799 (2007).
21. Kamiya, M. et al. An enzymatically activated fluorescence probe for targeted tumor imaging. J. Am. Chem. Soc. 129, 3918-3929 (2007).
22. Hoffman, R.M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat. Rev. Cancer 5, 796-806 (2005).
23. Baselga, J., Norton, L., Albanell, J., Kim, Y.M. & Mendelsohn, J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825-2831 (1998).
24. Gancberg, D. et al. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann. Oncol. 13, 1036-1043 (2002).
25. Zidan, J. et al. Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease. Br. J. Cancer 93, 552-556 (2005).
26. Mandler, R., Kobayashi, H., Hinson, E.R., Brechbiel, M.W. & Waldmann, T.A. Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity. Cancer Res. 64, 1460-1467 (2004).
27. Hama, Y., Urano, Y., Koyama, Y., Choyke, P.L. & Kobayashi, H. D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine green. J. Biomed. Opt. 12, 051501 (2007).
28. Alencar, H. et al. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection - study in mice. Radiology 244, 232-238 (2007).
29. De Grand, A.M. & Frangioni, J.V. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol. Cancer Res. Treat. 2, 553-562 (2003).
30. Parker, C.A. & Rees, W.T. Correction of fluorescence spectra and measurement of fluorescence quantum efficiency. Analyst 85, 587-600 (1960).
31. Koyama, Y., Hama, Y., Urano, Y., Nguyen, D.M., Choyke, P.L. & Kobayashi, H. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin. Cancer Res. 13, 2936-2945 (2007).
32. Levenson, R.M. & Mansfield, J.R. Multispectral imaging in biology and medicine: slices of life. Cytometry A. 69, 748-758 (2006).